Here’s a concise update on the latest news regarding oesophageal cancer.
Immunotherapy advances: Recent UK and global research funding aims to develop RNA-based immunotherapies and other immune-boosting treatments for oesophageal cancer, with early lab work focusing on restoring anti-cancer immune responses and preparing for potential clinical trials. These developments could lead to new treatment options beyond standard chemotherapy and surgery.[1][2][3][4]
New treatment strategies: As of 2025–2026, there are reports of newly approved first-line therapies and expanded indications for certain immunotherapies in oesophageal cancer, reflecting a shift toward combination regimens and personalized approaches.[4]
Awareness and research momentum: Oesophageal cancer awareness campaigns and ongoing research collaborations continue to advance understanding of how this cancer develops and how to prevent or treat it, including studies using three-dimensional cell culture models and multidisciplinary partnerships.[3][7]
Patient outcomes and longevity: While survival remains variable, some immunotherapies have shown meaningful long-term survival benefits in advanced disease, underscoring the importance of enrolling eligible patients in trials and considering immunotherapy options in appropriate settings.[8][4]
Illustration
If you’d like, I can curate a briefing focused on:
Would you prefer a short bullet-point brief or a more detailed explainer with timelines and trial names? For location relevance, I can tailor to France or Europe-wide data if you’d like.[2][3][4][8][1]
February is oesophageal cancer awareness month, and while oesophageal might be a lesser-known cancer, the early symptoms - heartburn and acid reflux – are a familiar experience for many of us.
www.lancashireandsouthcumbria.icb.nhs.ukTogether with Guts-UK we are supporting Dr Maria Alcolea at the University of Cambridge to carry out pioneering research about how oesophageal cancer emerges.
www.worldwidecancerresearch.orgLearn more about Cancer Research UK’s oesophageal cancer research. Hear stories about our scientists and people whose lives have been changed by our research.
www.cancerresearchuk.orgThe Christie NHS Foundation Trust and The University of Manchester have been awarded half a million pounds of funding from the Medical Research Council to produce a new immunotherapy for oesophageal cancer patients.
www.christie.nhs.ukResearchers co-funded by Worldwide Cancer Research and Guts UK have made a discovery that fundamentally changes our understanding of oesophageal cancer and how to treat it. Learn more.
www.worldwidecancerresearch.orgRecently approved therapies and novel insights into optimizing treatment strategies may offer new options for esophageal cancer patients.
www.aacr.orgTwo new treatment options using immunotherapy for patients with advanced oesophageal cancer have shown significantly improved long-term survival,…
www.royalmarsden.orgDavid was diagnosed with oesophageal cancer in October 2021. He had surgery and went on a clinical trial at The Christie and is now cancer-free.
www.christie.nhs.ukecancer
ecancer.org